1,128 assets in Non-Small Cell Lung Carcinoma

Therapeutic assets addressing Non-Small Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Jskn016 Non-Small Cell Lung Carcinoma	Shanghai Pulmonary Hospital, Shanghai, China	P2	B (58)
Midazolam Non-Small Cell Lung Carcinoma	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P4	B (58)
mk-0482 Non-Small Cell Lung Carcinoma	Merck Sharp & Dohme LLC	P2	B (58)
mk-4830 Non-Small Cell Lung Carcinoma	Merck Sharp & Dohme LLC	P2	B (58)
Monalizumab Non-Small Cell Lung Carcinoma	Montefiore Medical Center	P3	B (58)
nc318 Non-Small Cell Lung Carcinoma	NextCure, Inc.	P2	B (58)
Obinutuzumab Non-Small Cell Lung Carcinoma	NeoTX Therapeutics Ltd.	P2	B (58)
Oritinib Non-Small Cell Lung Carcinoma	Nanjing Sanhome Pharmaceutical, Co., Ltd.	P3	B (58)
S-1 Non-Small Cell Lung Carcinoma	Genentech, Inc.	P3	B (58)
Selpercatinib Non-Small Cell Lung Carcinoma	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	P3	B (58)
Sotorasib Non-Small Cell Lung Carcinoma	National Cancer Institute (NCI)	P3	B (58)
sy-3505 Non-Small Cell Lung Carcinoma	Shouyao Holdings (Beijing) Co. LTD	P3	B (58)
sys6010 Non-Small Cell Lung Carcinoma	CSPC Megalith Biopharmaceutical Co.,Ltd.	P3	B (58)
Tamoxifen Non-Small Cell Lung Carcinoma	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	P3	B (58)
TIL Non-Small Cell Lung Carcinoma	Tianjin Medical University General Hospital	P2	B (58)
Trametinib Non-Small Cell Lung Carcinoma	Novartis Pharmaceuticals	P4	B (58)
Tunlametinib Non-Small Cell Lung Carcinoma	Sun Yat-sen University	P2	B (58)
Volrustomig Non-Small Cell Lung Carcinoma	AstraZeneca	P3	B (58)
wx-0593 Non-Small Cell Lung Carcinoma	Pingping Song	P3	B (58)
Zirconium Zr 89 Crefmirlimab Berdoxam Non-Small Cell Lung Carcinoma	Memorial Sloan Kettering Cancer Center	P2/3	B (58)
18f-alfatide Non-Small Cell Lung Carcinoma	Yantai LNC Biotechnology Singapore PTE. LTD.	P3	B (57)
Berzosertib Non-Small Cell Lung Carcinoma	National Cancer Institute (NCI)	P1/2	B (57)
Cobalamin Non-Small Cell Lung Carcinoma	AstraZeneca	P3	B (57)
Cobicistat Non-Small Cell Lung Carcinoma	Maastricht University Medical Center	P4	B (57)
Daratumumab Non-Small Cell Lung Carcinoma	Georgetown University	P2	B (57)
Fludarabine Non-Small Cell Lung Carcinoma	University of Pennsylvania	P3	B (57)
Hyaluronidase Fihj Non-Small Cell Lung Carcinoma	NYU Langone Health	P2	B (57)
Immunoglobulin G1, Anti-(Human Interleukin-1 Receptor Accessory Protein) (Human-Mus Musculus Monoclonal Can04 .Gamma.1-Chain), Disulfide With Human-Mus Musculus Monoclonal Can04 .Kappa.-Chain, Dimer Non-Small Cell Lung Carcinoma	Cantargia AB	P1/2	B (57)
Magnesiocard Non-Small Cell Lung Carcinoma	Swiss Cancer Institute	P2/3	B (57)
MAT2A-IN-9 Non-Small Cell Lung Carcinoma	IDEAYA Biosciences	P1/2	B (57)
Nogapendekin Alfa Non-Small Cell Lung Carcinoma	SWOG Cancer Research Network	P2/3	B (57)
Pemigatinib Non-Small Cell Lung Carcinoma	Incyte Corporation	P2	B (57)
Pralsetinib, Trans- Non-Small Cell Lung Carcinoma	Fudan University	P3	B (57)
prt3789 Non-Small Cell Lung Carcinoma	Prelude Therapeutics	P2	B (57)
Ruxolitinib Non-Small Cell Lung Carcinoma	University of California, San Diego	P2	B (57)
Sevabertinib Non-Small Cell Lung Carcinoma	Bayer	P3	B (57)
Abt-700-Vcmmae Non-Small Cell Lung Carcinoma	Jonsson Comprehensive Cancer Center	P3	B (56)
Aglatimagene Besadenovec Non-Small Cell Lung Carcinoma	Candel Therapeutics, Inc.	P3	B (56)
Anlotinib Hydrochloride Capsules Non-Small Cell Lung Carcinoma	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	P3	B (56)
Binimetinib Non-Small Cell Lung Carcinoma	Peking University Cancer Hospital & Institute	P2	B (56)
Ct-P51 Non-Small Cell Lung Carcinoma	Celltrion	P3	B (56)
Domvanalimab Non-Small Cell Lung Carcinoma	Gilead Sciences	P3	B (56)
Entrectinib Non-Small Cell Lung Carcinoma	Fudan University	P3	B (56)
Fhnd-9041 Non-Small Cell Lung Carcinoma	Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.	P3	B (56)
Glutamine Non-Small Cell Lung Carcinoma	Instituto Nacional de Cancerologia de Mexico	P3	B (56)
Gotistobart Non-Small Cell Lung Carcinoma	OncoC4, Inc.	P3	B (56)
hlx208 Non-Small Cell Lung Carcinoma	Shanghai Henlius Biotech	P2	B (56)
Itraconazole Non-Small Cell Lung Carcinoma	Eli Lilly and Company	P2	B (56)
Jab-21822 Non-Small Cell Lung Carcinoma	Allist Pharmaceuticals, Inc.	P3	B (56)
pf-08046054 Non-Small Cell Lung Carcinoma	Pfizer	P3	B (56)

Showing 201 to 250 of 1,128 assets

PreviousPage 5 of 23Next